Mar 07, 2023 / 04:35PM GMT
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Research Analyst
Good morning, everyone. I'm Andrew Cooper, Lead Diagnostics Analyst here at Raymond James. Happy to be joined by the QuidelOrtho team, this morning.
With me is Doug Bryant, CEO; and Bryan Brokmeier with IR.
Questions and Answers:
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Research AnalystWithout further ado, we're going to do a fireside chat, so we will just dive right into it. Maybe Doug, just start us off, can you take a few minutes and give us, some folks that might be a little bit newer to the story, background on the company, areas of the market you play in, and how you're positioned and how that's changed over the past few years as we think about adding in the Ortho business and so on.
Douglas C. Bryant - QuidelOrtho Corporation - President, CEO & Director
Sure. Well, first of all, Andrew, thanks for having us. Closed the deal at the end of May last year, it